doi : 10.1161/STR.0000000000000425
Volume 54(2) pgs. 291-638,e25-e51 February 2023
Rawlley, Bharat MBBS; Marchina, Sarah PhD; Cappucci, Stefanie P. MD; Gogia, Bhanu MD; Wang, Jia-Yi MD; Stillman, Alexandra MD; Kumar, Sandeep MD
doi : 10.1161/STROKEAHA.122.039173
Gender disparities among principal investigators of clinical trials (CT) can have implications regarding the areas of investigation, methods, conduct, trial enrollment, and interpretation of results. An estimation of the gender gap in the leadership of stroke-related CTs from North America has to date not been undertaken.
Walter, Silke MD; Sacco, Simona MD; Sandset, Else Charlotte MD, PhD
Koemans, Emma A. MD; Castello, Juan Pablo MD; Rasing, Ingeborg MD; Abramson, Jessica R. BA; Voigt, Sabine BSc; Perosa, Valentina MD; van Harten, Thijs W. MSc; van Zwet, Erik W. PhD; Terwindt, Gisela M. MD, PhD; Gurol, M. Edip MD, PhD; Rosand, Jonathan MD; Greenberg, Steven M. MD, PhD; van Walderveen, Marianne A.A. MD, PhD; Biffi, Alessandro MD, PhD; Viswanathan, Anand MD, PhD ,*; Wermer, Marieke J.H. MD, PhD ,*
doi : 10.1161/STROKEAHA.122.040823
Cerebral Amyloid Angiopathy (CAA) disease course is highly variable even in hereditary forms. Sex may be a possible modifying factor. We investigated biological sex differences in clinical disease course and magnetic resonance imaging-markers in sporadic (sCAA) and Dutch-type hereditary CAA (D-CAA).
van Dam-Nolen, Dianne H.K. MD; van Egmond, Nina C.M. BSc; Koudstaal, Peter J. MD, PhD; van der Lugt, Aad MD, PhD; Bos, Daniel MD, PhD
doi : 10.1161/STROKEAHA.122.041046
Over the last decades, several individual studies on sex differences in carotid atherosclerosis have been performed covering a wide range of plaque characteristics and including different populations.
Sun, Dapeng MD; Raynald, MD; Huo, Xiaochuan MD; Jia, Baixue MD; Tong, Xu MD; Ma, Gaoting MD; Wang, Anxin PhD; Ma, Ning MD; Gao, Feng MD; Mo, Dapeng MD; Nguyen, Thanh N. MD; Miao, Zhongrong MD; on behalf of ANGEL-ACT Study Group; Miao, Zhongrong; Gui, Liqiang; Song, Cunfeng; Peng, Ya; Wu, Jin; Zhao, Shijun; Zhao, Junfeng; Zhou, Zhiming; Li, Yongli; Jing, Ping; Yang, Lei; Liu, Yajie; Zhao, Qingshi; Liu, Yan; Peng, Xiaoxiang; Gao, Qingchun; Guo, Zaiyu; Chen, Wenhuo; Li, Weirong; Cheng, Xiaojiang; Xu, Yun; Zhang, Yongqiang; Zhang, Guilian; Lu, Yijiu; Lu, Xinyu; Wang, Dengxiang; Wang, Yan; Li, Hao; Hua, Yang; Geng, Deqin; Yuan, Haicheng; Wang, Hongwei; Yang, Haihua; Wang, Zengwu; Wei, Liping; Liufu, Xuancong; Shi, Xiangqun; Li, Juntao; Yang, Wenwu; Jing, Wenji; Yong, Xiang; Wang, Leyuan; Li, Chunlei; Cao, Yibin; Zhu, Qingfeng; Zhang, Peng; Luo, Xiang; Chen, Shengli; Peng, WenWu; Wang, Lixin; Wen, Xue; Shi, Shugui; Wang, Wanming; Bo, Wang; Yuan, Pu; Wang, Dong; Guan, Haitao; Liang, Wenbao; Ma, Daliang; Chen, Long; Xiao, Yan; Xie, Xiangdong; Shi, Zhonghua; Zeng, Xiangjun; Su, Fanfan; Chang, MingZe; Yin, Jijun; Sun, Hongxia; Li, Chong; Bi, Yong; Xie, Gang; Zhao, Yuwu; Wang, Chao; Zhang, Peng; Wang, Xianjun; Li, Dongqun; Liang, Hui; Chen, Zhonglun; Wang, Yan; Wang, Yuxin; Yin, Lin; Qiu, HongKai; Wei, Jun; Sun, Yaxuan; Feng, Xiaoya; Wu, Weihua; Gao, Lianbo; Ai, Zhibing; Tan, Lan; Ding, Li; Liang, Qilong; Wang, Zhimin; Yang, Jianwen; Xu, Ping; Dong, Wei; Zheng, Quanle; Zhu, Zhenyun; Zhao, Liyue; Meng, Qingbo; Wei, Yuqing; Chen, Xianglin; Wang, Wei; Sun, Dong; Yan, Yongxing; Yuan, Guangxiong; Yang, Yadong; Zhou, Jianfeng; Yang, Zhi; Zhang, Zhenzhong; Guan, Ning; Wang, Huihong
doi : 10.1161/STROKEAHA.122.041195
Sex disparities in acute large vessel occlusion (LVO) following endovascular treatment (EVT) have been recently reported. However, there is uncertainty about the effect of sex differences on functional outcomes after EVT, particularly in an Asian population.
Yu, Amy Y.X. MD, MSc; Nerenberg, Kara A. MD, MSc; Diong, Christina MSc; Fang, Jiming PhD; Chu, Anna MSc; Kapral, Moira K. MD, MSc; Edwards, Jodi D. PhD; Dancey, Sonia R.; Austin, Peter C. PhD; Auger, Nathalie MD, MSc
doi : 10.1161/STROKEAHA.122.041471
Pregnancy-associated stroke carries high short-term morbidity and mortality, but data on subsequent maternal outcomes are limited. We evaluated long-term maternal health outcomes after pregnancy-associated stroke.
Oliveira, Lara C. MD; Ponciano, Ana MD, MSc; Tuozzo, Carissa BS; Viswanathan, Anand MD, PhD; Rost, Natalia S. MD, MPH; Etherton, Mark R. MD, PhD
doi : 10.1161/STROKEAHA.122.041502
Ischemic stroke (IS) is a leading cause of long-term disability with sex-specific differences in outcomes. Identifying the influential factors that contribute to sex-specific disparities in stroke outcomes, therefore, holds potential to develop individualized interventions for reducing long-term disability.
Cipolla, Marilyn J. PhD; Tremble, Sarah M. BS; DeLance, Nicole BS; Johnson, Abbie C. PhD
doi : 10.1161/STROKEAHA.122.041637
Preeclampsia increases the incidence of maternal stroke, a devastating condition that is on the rise. We investigated stroke outcome in a model of experimental preeclampsia with and without treatment with clinically relevant doses of magnesium sulfate (experimental preeclampsia+MgSO4) compared to normal late-pregnant and nonpregnant rats.
Zhu, Wenbin MD; Davis, Catherine M. PhD; Allen, Elyse M. BA, BS; Feller, Sarah L. BS; Bah, Thierno M. PhD; Shangraw, Robert E. MD, PhD; Wang, Ruikang K. PhD; Alkayed, Nabil J. MD, PhD
doi : 10.1161/STROKEAHA.122.040972
Type 2 diabetes (DM2) exacerbates stroke injury, reduces efficacy of endovascular therapy, and worsens long-term functional outcome. Sex differences exist in stroke incidence, response to therapy, poststroke microvascular dysfunction, and functional recovery.
Towfighi, Amytis MD; Ovbiagele, Bruce MD, MSc, MAS, MBA, MLS
doi : 10.1161/STROKEAHA.122.041892
AB There are stark inequities in stroke incidence, prevalence, care, and outcomes. This issue of Stroke features manuscripts from the third annual HEADS-UP (Health Equity and Actionable Disparities in Stroke: Understanding and Problem-Solving) symposium, which took place the day before the International Stroke Conference in February 2022.
Kapral, Moira K. MD, MSc
doi : 10.1161/STROKEAHA.122.039562
AB Inequities in stroke care and outcomes have been documented both within and among countries based on factors, such as race, geography, and socioeconomic status. Research can help us to identify, understand, and address inequities, and this article offers considerations for scientists working in this area.
Reeves, Mathew J. PhD; Boden-Albala, Bernadette PhD; Cadilhac, Dominique A. PhD
doi : 10.1161/STROKEAHA.122.039565
AB In many countries hospital length of stay after an acute stroke admission is typically just a few days, therefore, most of a person's recovery from stroke occurs in the community.
Sharrief, Anjail Z. MD, MPH; Guzik, Amy K. MD; Jones, Erica MD, MPH; Okpala, Munachi MSN, NP-C, DNP; Love, Mary F. MSN, RN, PhD; Ranasinghe, Tamra Ishan Jayenda MD; Bushnell, Cheryl MD, MS
doi : 10.1161/STROKEAHA.122.039566
AB Telehealth has seen rapid expansion into chronic care management in the past 3 years because of the COVID-19 pandemic. Telehealth for acute care management has expanded access to equitable stroke care to many patients over the past two decades, but there is limited evidence for its benefit for addressing disparities in the chronic care of patients living with stroke
Sarfo, Fred Stephen MD, PhD; Nichols, Michelle PhD, RN; Opare-Addo, Priscilla Abrafi MD; Ovbiagele, Bruce MD, MSc, MAS, MBA, MLS
doi : 10.1161/STROKEAHA.122.039567
AB Current projections are that the already overwhelming burden of strokes and atherosclerotic cardiovascular diseases in low- and middle-income countries (LMICs) will continue to rise over the coming decades as the prevalence of traditional vascular risk factors burgeon in these countries.
Mackey, Jason MD; Yamal, Jose-Miguel PhD; Parker, Stephanie A. MHA; Silnes, Kelly MS; Rajan, Suja S. PhD; Jacob, Asha P. MD; Wang, Mengxi PhD; Singh, Noopur MPH; Jones, William J. MD; Spokoyny, Ilana MD; Navi, Babak B. MD; Saver, Jeffrey L. MD; Grotta, James C. MD; for the BEST-MSU Study Group
doi : 10.1161/STROKEAHA.122.039821
Treatment of patients with acute ischemic stroke on mobile stroke units (MSUs) improves outcomes compared with management by standard emergency medical services ambulances and is associated with more patients treated with intravenous tPA (tissue-type plasminogen activator) in the first golden hour after last known normal.
Tanaka, Kanta MD, PhD; Reeves, Mathew J. PhD
Rodrigo-Gisbert, Marc MD; Requena, Manuel MD, PhD; Rubiera, Marta MD, PhD; Khalife, Jane MD; Lozano, Prudencio MD; De Dios Lascuevas, Marta MD; Garcia-Tornel, Alvaro MD, PhD; Olive-Gadea, Marta MD, PhD; Pinana, Carlos MD; Rizzo, Federica MD; Boned, Sandra MD, PhD; Muchada, Marian MD, PhD; Rodriguez-Villatoro, Noelia MD, PhD; Rodriguez-Luna, David MD, PhD; Juega, Jesus MD, PhD; Pagola, Jorge MD, PhD; Hernandez, David MD; Molina, Carlos A. MD, PhD; Tomasello, Alejandro MD; Ribo, Marc MD, PhD
doi : 10.1161/STROKEAHA.122.041257
Acute ischemic stroke with large or medium-vessel occlusion associated with intracranial artery calcification (IAC) is an infrequent phenomenon presumably associated with intracranial atherosclerotic disease. We aimed to characterize IAC and its impact on endovascular treatment outcomes.
Ekker, Merel S. MD; Verhoeven, Jamie I. MD; Schellekens, Mijntje M.I. MD; Boot, Esther M. MD; van Alebeek, Mayte E. MD, PhD; Brouwers, Paul J.A.M. MD, PhD; Arntz, Renate M. MD, PhD; van Dijk, Gert W. MD, PhD; Gons, Rob A.R. MD, PhD; van Uden, Inge W.M. MD, PhD; den Heijer, Tom MD, PhD; de Kort, Paul L.M. MD, PhD; de Laat, Karlijn F. MD, PhD; van Norden, Anouk G.W. MD, PhD; Vermeer, Sarah E. MD, PhD; van Zagten, Marian S.G. MD, PhD; van Oostenbrugge, Robert J. MD, PhD; Wermer, Marieke J.H. MD, PhD; Nederkoorn, Paul J. MD, PhD; Zonneveld, Thomas P. MD; Kerkhoff, Henk MD, PhD; Rooyer, Fergus A. MD; van Rooij, Frank G. MD, PhD; van den Wijngaard, Ido R. MD, PhD; Klijn, Catharina J.M. MD, PhD; Tuladhar, Anil M. MD, PhD; de Leeuw, Frank-Erik MD, PhD
doi : 10.1161/STROKEAHA.122.040524
Identification of risk factors and causes of stroke is key to optimize treatment and prevent recurrence. Up to one-third of young patients with stroke have a cryptogenic stroke according to current classification systems (Trial of ORG 10172 in Acute Stroke Treatment [TOAST] and atherosclerosis, small vessel disease, cardiac pathology, other causes, dissection [ASCOD]).
Bala, Fouzi MD, MSc; Kappelhof, Manon MD, PhD; Ospel, Johanna M. MD, PhD; Cimflova, Petra MD; Qiu, Wu PhD; Singh, Nishita MD; Zhu, Kairan PhD; Kim, Beom Joon MD, PhD; Wadhwa, Ankur MD; Almekhlafi, Mohammed A. MD, MSc; Menon, Bijoy K. MD, MSc; Arrarte Terreros, Nerea PhD; Marquering, Henk MD, PhD; Majoie, Charles MD, PhD; Hill, Michael D. MD, MSc; Goyal, Mayank MD, PhD; for the ESCAPE-NA1 Investigators
doi : 10.1161/STROKEAHA.122.040542
Distal embolization (DE) is a common complication of endovascular treatment (EVT). We investigated the association of radiological thrombus characteristics and treatment details with DE.
Leung, Ya Yuan Rachel MB, ChB; Bera, Kasia DPhil; Urriza Rodriguez, Daniel FRCS; Dardik, Alan MD, PhD; Mas, Jean-Louis MD; Simonte, Gioele MD, PhD; Rerkasem, Kittipan MD, PhD; Howard, Dominic P.J. DPhil
doi : 10.1161/STROKEAHA.122.040819
There is uncertainty whether elderly patients with symptomatic carotid stenosis have higher rates of adverse events following carotid endarterectomy. In trials, recurrent stroke risk on medical therapy alone increased with age, whereas operative stroke risk was not related.
Dong, Chuanhui PhD; Gardener, Hannah ScD; Rundek, Tatjana MD, PhD; Marulanda, Erika MD, MS; Gutierrez, Carolina M. PhD; Campo-Bustillo, Iszet MD, MPH; Gordon Perue, Gillian MBBS, DM; Johnson, Karlon H. MPH; Sacco, Ralph L. MD, MS; Romano, Jose G. MD; on behalf of the Transitions of Care Stroke Disparities Study (TCSD-S) Investigators
doi : 10.1161/STROKEAHA.122.040891
Our objective is to describe adoption of the posthospitalization behaviors associated with successful transition of care and related baseline characteristics.
van der Ende, Nadinda A.M. MD; Kremers, Femke C.C. MSc; van der Steen, Wouter MD; Venema, Esmee MD, PhD; Kappelhof, Manon MD, PhD; Majoie, Charles B.L.M. MD, PhD; Postma, Alida A. MD, PhD; Boiten, Jelis MD, PhD; van den Wijngaard, Ido R. MD, PhD; van der Lugt, Aad MD, PhD; Dippel, Diederik W.J. MD, PhD; Roozenbeek, Bob MD, PhD; on behalf of the MR CLEAN Registry Investigators
doi : 10.1161/STROKEAHA.122.040065
Symptomatic intracranial hemorrhage (sICH) is a severe complication of reperfusion therapy for ischemic stroke. Multiple models have been developed to predict sICH or intracranial hemorrhage (ICH) after reperfusion therapy.
Jiang, Liang MD ,*; Miao, Zhengfei MD ,*; Chen, Huiyou MD; Geng, Wen MD; Yong, Wei MD; Chen, Yu-Chen PhD; Zhang, Hong MD; Duan, Shaofeng PhD; Yin, Xindao PhD; Zhang, Zhiqiang PhD
doi : 10.1161/STROKEAHA.122.040418
Diffusion-weighted imaging radiomics could be used as prognostic biomarkers in acute ischemic stroke. We aimed to identify a clinical and diffusion-weighted imaging radiomics model for individual unfavorable outcomes risk assessment in acute ischemic stroke.
Vecchio, Fabrizio PhD; Pappalettera, Chiara MSc; Miraglia, Francesca PhD; Deinite, Gregorio MD; Manenti, Rosa PhD; Judica, Elda MD, PhD; Caliandro, Pietro MD, PhD; Rossini, Paolo Maria MD, PhD
doi : 10.1161/STROKEAHA.122.040747
The objective of the present study is to explore whether acute stroke may result in changes in brain network architecture by electroencephalography functional coupling analysis and graph theory.
Zhu, Zhengbao MD, PhD; Guo, Daoxia MD, PhD; Zhang, Kaixin MD; Yang, Pinni MD; Jia, Yiming MD; Shi, Mengyao MD, PhD; Peng, Yanbo MD, PhD; Chen, Jing MD, MS; Wang, Aili MD, PhD; Xu, Tan MD, PhD; Zhang, Yonghong MD, PhD; He, Jiang MD, PhD
doi : 10.1161/STROKEAHA.122.040800
Osteoprotegerin was implicated in vascular injury and inflammatory responses, but its prognostic value in ischemic stroke remained unclear. We aimed to prospectively investigate the association between plasma osteoprotegerin and ischemic stroke prognosis combined with a Mendelian randomization analysis.
Chen, Huanwen MD ,,,*; Khunte, Mihir BS ,,*; Colasurdo, Marco MD; Jindal, Gaurav MD; Malhotra, Ajay MD; Gandhi, Dheeraj MD; Chaturvedi, Seemant MD
doi : 10.1161/STROKEAHA.122.041749
Osteoarthritis and other musculoskeletal disorders are the leading causes of disability in the United States. While osteoarthritis is not a direct risk factor for stroke, osteoarthritis may impact patient selection for endovascular thrombectomy (EVT) due to prestroke disability.
Moura, Lidia M.V.R. MD, PhD, MPH; Donahue, Maria A. MD; Yan, Zhiyu MS; Smith, Louisa H. PhD; Hsu, John MD, MBA, MSCE; Newhouse, Joseph P. PhD; Schwamm, Lee H. MD; Haneuse, Sebastien PhD; Hernandez-Diaz, Sonia MD, DPH; Blacker, Deborah MD, ScD
doi : 10.1161/STROKEAHA.122.039946
Older adults occasionally receive seizure prophylaxis in an acute ischemic stroke (AIS) setting, despite safety concerns. There are no trial data available about the net impact of early seizure prophylaxis on post-AIS survival.
Liu, Chi-Hung MD, MSc ,,*; Wu, Yi-Ling DrPH ,*; Hsu, Chih-Cheng MD, DrPH ,,+; Lee, Tsong-Hai MD, PhD ,+
doi : 10.1161/STROKEAHA.122.040500
The appropriate timing of resuming antithrombotic therapy after intracerebral hemorrhage (ICH) remains unclear. The aim of this study was to compare the risks of major bleeding between early and late antiplatelet resumption in ICH survivors.
Balali, Pargol MD; Katsanos, Aristeidis H. MD, PhD; Shoamanesh, Ashkan MD
Tozer, Daniel J. PhD; Brown, Robin B. MRCP; Walsh, Jessica PhD; Hong, Young T. PhD; Williams, Guy B. PhD; O'Brien, John T. DM; Aigbirhio, Franklin I. DPhil; Fryer, Tim D. PhD; Markus, Hugh S. DM
doi : 10.1161/STROKEAHA.122.039517
Recent studies have demonstrated increased microglial activation using 11C-PK11195 positron emission tomography imaging, indicating central nervous system inflammation, in cerebral small vessel disease. However, whether such areas of neuroinflammation progress to tissue damage is uncertain.
Alzahrani, Awad MSc; Zhang, Xinyu MPH; Albukhari, Adel MD; Wardlaw, Joanna M. MD; Mair, Grant MD
doi : 10.1161/STROKEAHA.122.041241
Treatment for ischemic stroke can be offered beyond conventional time limits for patients with favorable computed tomography perfusion (CTP), but this is not universally available.
Morotti, Andrea MD; Boulouis, Gregoire MD, PhD; Nawabi, Jawed MD; Li, Qi MD, PhD; Charidimou, Andreas MD, PhD; Pasi, Marco MD, PhD; Schlunk, Frieder MD; Shoamanesh, Ashkan MD; Katsanos, Aristeidis H. MD; Mazzacane, Federico MD; Busto, Giorgio MD; Arba, Francesco MD, PhD; Brancaleoni, Laura MD; Giacomozzi, Sebastiano MD; Simonetti, Luigi MD; Warren, Andrew D. BS; Laudisi, Michele MD; Cavallini, Anna MD; Gurol, Edip M. MD, MSc; Viswanathan, Anand MD, PhD; Zini, Andrea MD; Casetta, Ilaria MD, PhD; Fainardi, Enrico MD, PhD; Greenberg, Steven M. MD, PhD; Padovani, Alessandro MD, PhD; Rosand, Jonathan MD, MSc; Goldstein, Joshua N. MD, PhD
doi : 10.1161/STROKEAHA.122.041302
Noncontrast computed tomography hypodensities are a validated predictor of hematoma expansion (HE) in intracerebral hemorrhage and a possible alternative to the computed tomography angiography (CTA) spot sign but their added value to available prediction models remains unclear.
Choi, Jun Young MD, PhD ,,*; Jin, Xuelian MD ,,,*; Kim, Hanki MD; Koh, Seungyon MD; Cho, Hyo Jin MS; Kim, Byung Gon MD, PhD
doi : 10.1161/STROKEAHA.122.041414
The migration of oligodendrocyte precursor cells (OPC) is a key process of remyelination, which is essential for the treatment of white matter stroke. This study aimed to investigate the role of HMGB1 (high mobility group box 1), a damage-associated molecular pattern released from dying oligodendrocytes, as an autocrine chemoattractant that promotes OPC migration.
Vanderschelden, Benjamin MD; Erani, Fareshte MS; Wu, Jennifer MD, PhD; de Havenon, Adam MD; Srinivasan, Ramesh PhD; Cramer, Steven C. MD
doi : 10.1161/STROKEAHA.122.040841
Clinical and neuroimaging measures incompletely explain behavioral deficits in the acute stroke setting. We hypothesized that electroencephalography (EEG)-based measures of neural function would significantly improve prediction of acute stroke deficits.
Zheng, Ming MD, PhD ,,*; Zheng, Shaoping MMedSci ,*
Lekoubou, Alain MD, MS; Srinivasan, Pavitra MD; Kanekar, Sangam G. MD
Jensen-Kondering, Ulf MD; Johannes Koch, Philipp MD; Hagelstein, Victoria MD
Schlechter, Maia BA; Lucey, Kenia MD; Peng, Teng J. MD; Amin, Hardik MD
Fukutome, Kenji MD, PhD; Shiba, Mikio MD, PhD; Matsuoka, Ryuta MD, PhD; Aketa, Shuta MD, PhD; Motoyama, Yasushi MD, PhD
Bushnell, Cheryl D. MD, MHS; Kapral, Moira K. MD, MSc
doi : 10.1161/STROKEAHA.122.041734
AB There has been a plethora of studies focused on female-specific risk factors and sex differences in stroke published in the past year. This article summarizes several of those novel studies which provide new knowledge about the field of stroke in women.
Campbell, Bruce C.V. MBBS, PhD; Hill, Michael D. MD, MSc; Nguyen, Thanh N. MD; Broderick, Joseph P. MD
Khot, Sandeep P. MD, MPH; Taylor, Breana L. MD; Longstreth, W.T. Jr MD, MPH; Brown, Arleen F. MD, PhD
doi : 10.1161/STROKEAHA.122.039524
AB Sleep is essential to human survival and overall vascular health. Sleep health encompasses the objective and subjective qualities associated with one's daily pattern of sleep and wakefulness and has become a growing clinical and public health concern.
Ohashi, Sarah N. BA ,,*; DeLong, Jonathan H. PhD ,,*; Kozberg, Mariel G. MD, PhD ,,*; Mazur-Hart, David J. MD ,*; van Veluw, Susanne J. PhD ,,+; Alkayed, Nabil J. MD, PhD ,+; Sansing, Lauren H. MD, MS ,,+
doi : 10.1161/STROKEAHA.122.037155
AB Hemorrhagic stroke is the deadliest form of stroke and includes the subtypes of intracerebral hemorrhage and subarachnoid hemorrhage. A common cause of hemorrhagic stroke in older individuals is cerebral amyloid angiopathy.
Morais, Andreia PhD; Locascio, Joseph J. PhD; Sansing, Lauren H. MD; Lamb, Jessica BS; Nagarkatti, Karisma MS; Imai, Takahiko PharmD, PhD; van Leyen, Klaus PhD; Aronowski, Jaroslaw MD, PhD; Koenig, James I. PhD; Bosetti, Francesca PhD; Lyden, Patrick MD; Ayata, Cenk MD, PhD; on behalf of the SPAN Investigators; Bosetti, Francesca PhD; Koenig, James I. PhD; Lyden, Patrick D. MD; Lamb, Jessica BS; Nagarkatti, Karisma MS; Hess, David C. MD; Kamat, Pradip K. PhD; Khan, Mohammad Badruzzaman PhD; Dhandapani, Krishnan PhD; Arbab, Ali S. MD, PhD; Siddiqui, Shahneela MS; Smith, Cameron MS; Nisar, Mohammad BS; Leira, Enrique C. MD, MS; Chauhan, Anil K. PhD; Dhanesha, Nirav PhD; Patel, Rakesh B. PhD; Kumskova, Mariia PhD; Thedens, Daniel PhD; Wang, Kai PhD; Ayata, Cenk MD, PhD; Morais, Andreia PhD; Imai, Takahiko PharmD, PhD; Qin, Tao; Jin, Xuyan PhD; Erdogan, Taylan Denis BS; Yu, Lili MD; Mandeville, Joseph B. PhD; Kimberly, William Taylor MD, PhD; Whittier, Jonah Patrick Weigand BS; Lo, Eng PhD; Arai, Ken PhD; Van Leyen, Klaus PhD; Sansing, Lauren H. MD; Hyder, Fahmeed PhD; Mihailovic, Jelena M. PhD; Sanganahalli, Basavaraju G. PhD; Diaz-Perez, Sebastian BS; Velazquez, Sofia E. BS; Beatty, Hannah E. BS; Johnson, Conor BS; Herman, Alison L. BA; Boisserand, Ligia S. B. PhD; Immakavar, Emma BS; Koehler, Raymond C. PhD; Dawson, Ted PhD; Dawson, Valina PhD; Shi, Yanrong MD, MS; Avery, Brooklyn BS; Lannon, Steven BS; Bibic, Adnan PhD; Akhter, Kazi PhD; Karuppagounder, Senthilkumar S. PhD; Aronowski, Jaroslaw MD, PhD; McCullough, Louise D. MD, PhD; Obertas, Lidiya PhD; Goh, Andrew MS; Huang, Shuning PhD; Chauhan, Anjali PhD.
doi : 10.1161/STROKEAHA.122.040638
AB The Stroke Preclinical Assessment Network (SPAN) is a multicenter preclinical trial platform using rodent models of transient focal cerebral ischemia to address translational failure in experimental stroke. In addition to centralized randomization and blinding and large samples, SPAN aimed to introduce heterogeneity to simulate the heterogeneity embodied in clinical trials for robust conclusions.
Broderick, Joseph P. MD; Aziz, Yasmin N. MD; Adeoye, Opeolu M. MD; Grotta, James C. MD; Naidech, Andrew M. MD, MSPH; Barreto, Andrew D. MD, MS; Derdeyn, Colin P. MD; Sucharew, Heidi J. PhD; Elm, Jordan J. PhD; Khatri, Pooja MD
doi : 10.1161/STROKEAHA.122.040071
AB Randomized clinical trials of acute stroke have led to major advances in acute stroke therapy over the past decade. Despite these successes, recruitment in acute trials is often difficult.
Bake, Shameena PhD; Sohrabji, Farida PhD
Volpe, Salvatore G. MA; Zuniga, Mary C. MD; Caunca, Michelle R. MD, PhD; Rosendale, Nicole MD
Theodorou, Aikaterini MD; Chondrogianni, Maria MD; Bakola, Eleni MD; Kaloudi, Georgia MD; Foska, Aikaterini MD; Michalakakou, Smaragdi MD; Melanis, Konstantinos MD; Paraskevas, Georgios P. MD; Tsivgoulis, Georgios MD
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟